Recent Posts

Big pharma’s metabolism is slowing down

The biggest players in pharma and biotech firms are in a rut, and even a heroic earnings season might not be enough to lift it out. The broader environment is positive: The Trump administration’s drug-pricing push is for now more sound than fury, the economy is humming, and new treatments are being approved at a rapid clip. And of course ...

Read More »

Amazon Prime Day could be even more prime

Happy birthday to Amazon. com Inc That is, after all, the occasion it’s marking with the Prime Day hoopla, right? Once again, it appears to be getting a pretty nice gift: heaps of media coverage for a 36-hour sprint of deals and discounts. But birthdays can also be a time for reflection. Amazon has become the default starting point for ...

Read More »

Banks would face a bust without tax-cut boom

Here’s the latest sign of who’s benefiting in President Donald Trump’s economy: Without the tax cut, bank earnings growth in the second quarter would have been pretty close to zilch. Instead, the nation’s six biggest banks are set to report a 14 percent improvement in earnings in the April-to-June period. Nine of every 10 dollars of that increase is thanks ...

Read More »
Send this to a friend